公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2010 | Erratum: Statistical test for evaluation of biosimilarity in variability of follow-on biologics (Journal of Biopharmaceutical Statistics 20:1 (75) | Hsieh, T.-C.; JEN-PEI LIU | Journal of Biopharmaceutical Statistics | | | |
1992 | Estimation of direct formulation effect under log-normal distribution in bioavailability/bioequivalence studies | JEN-PEI LIU ; Weng, C.-S. | Statistics in Medicine | | | |
1994 | Evaluation of log-transformation in assessing bioequivalence | JEN-PEI LIU ; JEN-PEI LIU | Communications in Statistics - Theory and Methods | | | |
1993 | Evaluation of parametric and nonparametric two one-sided tests procedures for assessing bioequivalence of average bioavailability | Liu, J.P.; JEN-PEI LIU | Journal of Biopharmaceutical Statistics | 4 | 0 | |
2015 | Evaluation of the parallel line assay for assessment of biosimilar products based on censored data | JEN-PEI LIU | Journal of the Chinese Statistical Association | | | |
2013 | Factors associated with falls among community-dwelling older people in Taiwan | Wu, T.Y.; Chie, W.C.; Yang, R.S.; JEN-PEI LIU ; Kuo, K.L.; Wong, W.K.; Liaw, C.K. | Annals of the Academy of Medicine Singapore | | | |
2007 | Factors associated with referral compliance of abnormal immunochemical faecal occult blood test | Li C.-M.; Shiu M.-N.; Chia S.-L.; Liu J.-P.; Chen, Tony Hsiu Hsi ; JEN-PEI LIU | Journal of Medical Screening | 6 | 6 | |
2010 | Guest Editors' Note | JEN-PEI LIU | Journal of Biopharmaceutical Statistics | | | |
2016 | Handbook of Adaptive Designs in Pharmaceutical and Clinical Development | JEN-PEI LIU | Handbook of Adaptive Designs in Pharmaceutical and Clinical Development | | | |
2004 | High incidence rate of hip fracture in Taiwan: Estimated from a nationwide health insurance database | WEI-CHU CHIE ; RONG-SEN YANG ; JEN-PEI LIU ; KEH-SUNG TSAI | Osteoporosis International | 108 | 95 | |
2013 | Immune gene expression profiles in swine inguinal lymph nodes with different viral loads of porcine circovirus type 2 | Lin C.-M.; Jeng C.-R.; Liu J.-P.; Lin E.-C.; Chang C.-C.; Huang Y.-L.; Tsai Y.-C.; Chia M.-Y.; Wan C.-H.; CHIAN-REN JENG ; VICTOR FEI PANG ; CHO-HUA WAN ; JEN-PEI LIU ; EN-CHUNG LIN | Veterinary Microbiology | 6 | 5 | |
2011 | Immunopathological characterization of porcine circovirus type 2 infection-associated follicular changes in inguinal lymph nodes using high-throughput tissue microarray | Lin, C.-M.; CHIAN-REN JENG ; Hsiao, S.-H.; JEN-PEI LIU ; Chang, C.-C.; Chiou, M.-T.; Tsai, Y.-C.; Chia, M.-Y.; VICTOR FEI PANG | Veterinary Microbiology | | | |
2017 | The impact of individualized nutritional support for patients with colorectal cancer who had undergone surgery | Guo Y.-C.; Liu J.-P.; JEN-PEI LIU | Taiwan Journal of Public Health | 0 | 0 | |
1998 | In vitro dissolution profile comparison- Statistics and analysis of the similarity factor, f2 | Shah, V.P.; Tsong, Y.; Sathe, P.; JEN-PEI LIU | Pharmaceutical Research | | | |
2000 | Individual bioequivalence: Preface | Chow S.-C.; JEN-PEI LIU | Statistics in Medicine | | | |
2009 | Inference on treatment effects for targeted clinical trials under enrichment design | JEN-PEI LIU ; Lin Jr.; R.; Chow, S.-C. | Pharmaceutical Statistics | | | |
2006 | Interim Analysis and Data Monitoring in Clinical Trials | Liu, Jen-Pei | | | | |
2005 | An Introduction to Statistical Evaluation of Drug Products | Liu, Jen-Pei | | | | |
2016 | Large-scale search method for locating and identifying fugitive emission sources in petrochemical processing areas | Yang J.-C.; Chang P.-E.; WEI-CHU CHIE ; Liu J.-P.; JEN-PEI LIU | Process Safety and Environmental Protection | 4 | 3 | |
1995 | Letter to the editor on “sample size for therapeutic equivalence based on confidence interval,” s. c. lin, drug information journal, 1995;29(1)45–50 | JEN-PEI LIU | Therapeutic Innovation & Regulatory Science | | | |